Increased plasminogen activator inhibitor-1 and vasculopathy: A reconcilable paradox

Circulation

Volumn 99, Issue 19, 1999, Pages 2496-2498

  Sobel, B E ^a  

^a University of Vermont Colchester Research Facility   (United States)

Author keywords

Coronary disease; Diabetes mellitus; Editorials; Plasminogen activators

Indexed keywords

LIPID; MATRIX METALLOPROTEINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; OXIDIZED LOW DENSITY LIPOPROTEIN; PLASMIN; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ANGINA PECTORIS; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL MIGRATION; EDITORIAL; HEART INFARCTION; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN DEGRADATION; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

EID: 0033580594     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.19.2496     Document Type: Editorial

References (41)